Inactive Instrument

Evogene Ltd. Stock TEL AVIV STOCK EXCHANGE

Equities

EVGN

IL0011050551

Biotechnology & Medical Research

Sales 2024 * 17M 64.5M Sales 2025 * 31.5M 120M Capitalization 34.63M 131M
Net income 2024 * -20M -75.89M Net income 2025 * -17M -64.5M EV / Sales 2024 * 2.04 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.1 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.27%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 58 01-12-31
Director of Finance/CFO 57 22-03-31
Chief Tech/Sci/R&D Officer 48 04-12-31
Members of the board TitleAgeSince
Director/Board Member 79 21-11-16
Chairman 58 16-08-10
Director/Board Member 76 05-04-30
More insiders
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
More about the company